Background illustration for clinical trials search

Paid Clinical Trials Houston

Discover 3,087 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

for
Acute Myeloid Leukemia, B-cell Acute Lymphoblastic Leukemia,
Location: Houston TX, Birmingham AL, Nashville TN, Cincinnati OH,
Sponsor: Vincerx Pharma, Inc.

Sex: All

Age: 18+

Code: NCT06034275

Phase1, Recruiting

A Study of ICP-192 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumors, Urothelial Carcinoma, Cholangiocarcinoma
Location: Houston TX, Aurora CO, Tucson AZ, Columbus OH,
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.

Sex: All

Age: 18+

Code: NCT04565275

Phase1, Phase2, Recruiting

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

for
Refractory Ewing Sarcoma, Relapsed Ewing Sarcoma, Ewing Sarcoma
Location: Houston TX, Dallas TX, Memphis TN, Atlanta GA,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 2 - 30

Code: NCT05734066

Phase1, Phase2, Recruiting

The Rise in Robotic Atypical Segmentectomies

for
Lung Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 0+

Code: NCT04644952

Recruiting

Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics

for
Breast Cancer, Colorectal Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05694559

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Ph I/II Trial of Cord Blood-derived NK Cells With NY-ESO-1 TCR/IL-15 for R/R Myeloma

for
Relapsed/Refractory Myeloma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18 - 70+

Code: NCT06066359

Phase1, Phase2, Recruiting

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

for
Metastatic Castration-resistant Prostate Cancer (mCRPC),
Location: Houston TX, Austin TX, Dallas TX, Germantown TN,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136650

Phase3, Recruiting